Protein glycosylation in development and disease

BioEssays

Volumn 21, Issue 5, 1999, Pages 412-421

  Dennis, James W ^a,b   Granovsky, Maria ^a,b   Warren, Charles E ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; GLYCOSYLTRANSFERASE; POLYSACCHARIDE;

ANIMAL; BIOSYNTHESIS; CARBOHYDRATE ANALYSIS; CHEMISTRY; GLYCOSYLATION; HUMAN; METABOLISM; MOLECULAR GENETICS; MOUSE; PROTEIN PROCESSING; REVIEW;

ANIMALS; CARBOHYDRATE SEQUENCE; GLYCOPROTEINS; GLYCOSYLATION; GLYCOSYLTRANSFERASES; HUMANS; MICE; MOLECULAR SEQUENCE DATA; POLYSACCHARIDES; PROTEIN PROCESSING, POST-TRANSLATIONAL;

ANIMALIA; METAZOA;

EID: 0033135747     PISSN: 02659247     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-1878(199905)21:5<412::AID-BIES8>3.0.CO;2-5     Document Type: Review

References (80)

1. Kornfeld R, Kornfeld S. Assembly of asparagine-linked oligosaccharides. Ann Rev Biochem 1985;54:631-664.
2. Schachter H. Biosynthetic controls that determine the branching and microheterogeneity of protein-bound oligosaccharides. Biochem Cell Biol 1986;64:163-181.
3. Varki A, Marth J. Oligosaccharides in vertebrate development. Seminars Dev Biol 1995;6:127-138.
4. Varki A. Biological roles of oligosaccharides: all of the theories are correct. Glycobiology 1993;3:97-130.
5. 4-4GalNAcα1,4GlcNAcβ1,Manα that mediates rapid clearance of lutropin. Cell 1991;67:1103-1110.
6. Takeuchi M, Kobata A. Structures and functional roles of the sugar chains of human erythropoietins. Glycobiology 1991;1:337-346.
7. Sheares BT, Robbins PW. Glycosylation of ovalbumin in a heterologous cell: analysis of oligosaccharide chains of the cloned glycoprotein in mouse L cells. Proc Natl Acad Sci USA 1986;83:1993-1997.
8. Rademacher TW, Parekh RB, Dwek RA. Glycobiology. Ann Rev Biochem 1988;57:785-838.
9. Gomez L, Chrispeels MJ. Complementation of an Arabidopsis thaliana mutant that lacks complex aparagine-linked glycans with the human cDNA encoding N-acetylglucosaminyltransferase I. Proc Natl Acad Sci USA 1994;91:1829-1833.
10. Metzler M, Gertz A, Sarkar M, Schachter H, Schrader JW, Marth JD. Complex asparagine-linked oligosaccharides are required for morphogenic events during post-implantation development. EMBO J 1994;13: 2056-2065.
11. Ioffe E, Stanley P. Mice lacking N-acetylglucosaminyltransferase I activity die at mid-gestation, revealing an essential role for complex or hybrid N-linked carbohydrates. Proc Natl Acad Sci USA 1994;91:728-732.
12. Stanley P, Sallustio S, Krag SS, Dunn B. Lectin-resistant CHO cells: selection of seven new mutants resistant to ricin. Somat Cell Mol Genet 1990;3:211-223.
13. Dennis JW, Laferte S, Waghorne C, Breitman ML, Kerbel RS. β1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis. Science 1987;236:582-585.
14. Elbein AD. Inhibitors of the biosynthesis and processing of N-linked oligosaccharides. CRC Crit Rev Biochem 1984;16:21-49.
15. Finnie JW, O'Shea JD. Acute hepatotoxicity with resultant pulmonary and cerebral embolism in guinea pigs given tunicamycin. Pathology 1989;21: 194-199.
16. Krasnewich DM, Holt GD, Brantly M, Skovby F, Redwine J, Gahl WA. Abnormal synthesis of dolichol-linked oligosaccharides in carbohydrate-deficient glycoprotein syndrome. Glycobiology 1995;5:503-510.
17. Hansen SH, Frank SR, Casanova JE. Cloning and characterization of human phosphomannomutase, a mammalian homologue of yeast SEC53. Glycobiology 1997;7:829-834.
18. Panneerselvam K, Etchison JR, Skovby F, Freeze HH. Abnormal metabolism of mannose in families with carbohydrate-deficient glycoprotein syndrome type 1. Biochem Mol Med 1997;61,161-167.
19. Alton G, Kjaergaard S, Etchison JR, Skovby F, Freeze HH. Oral ingestion of mannose elevates blood mannose levels: a first step toward a potential therapy for carbohydrate-deficient glycoprotein syndrome type I. Biochem Mol Med 1997;60:127-133.
20. 2 oligosaccharide as an initial step in recognizing unfolded glycoproteins. J Biol Chem 1995;270:4697-4704.
21. Sousa M, Parodi AJ. The molecular basis for the recognition of misfolded glycoproteins by the UDP-Glc:glycoprotein glucosyltransferase. EMBO J 1995;14:4196-4203.
22. Dahms NM, Lobel P, Kornfeld S. Mannose-6-phosphate receptors and lysosomal enzyme targeting. J Biol Chem 264:12115-12118.
23. Campbell RM, Metzler M, Granovsky M, Dennis JW, Marth JD. Complex asparagine-linked oligosaccharides in Mgat1-null embryos. Glycobiology 1995;5:535-543.
24. Ioffe E, Liu Y, Stanley P. Complex N-glycans in Mgatl null preimplantation embryos arise from maternal Mgat1 RNA. Glycobiology 1997;7:913-919.
25. Ioffe E, Liu Y, Stanley P. Essential role for complex N-glycans in forming an organized layer of bronchial epithelium. Proc Natl Acad Sci USA 1996;93: 11041-11046.
26. Moremen KW, Trimble RB, Herscovics A. Glycosidases of the asparagine-linked oligosaccharide processing pathway. Glycobiology 1994;4:113-125.
27. Chui D, Oh-Eda M, Liao YF, Panneerselvam K, Lal A, Marek KW, Freeze HH, Moremen KW, Fukuda MN, Marth JD. Alpha-mannosidase-II deficiency results in dyserythropoiesis and unveils an alternate pathway in oligosaccharide biosynthesis. Cell 1997;90:157-167.
28. Iolascon A, Miraglia del Giudice E, Perrotta S, Granatiero M, Zelante L, Gasparini P. Exclusion of three candidate genes as determinants of congenital dyserythropoietic anemia type II (CDA-II). Blood 1997;90:4197-4200.
29. Jaeken J, Schachter H, Carchon H, De Cock P, Coddeville B, Spik G. Carbohydrate deficient glycoprotein syndrome type II: a deficiency in Golgi localised N-acetyl-glucosaminyltransferase II. Arch Dis Child 1994; 71:123-127.
30. Tan J, Dunn J, Jaeken J, Schachter H. Mutations in the MGAT2 gene controlling complex N-glycan synthesis cause carbohydrate-deficient glycoprotein syndrome type II, an autosomal recessive disease with defective brain development. Am J Hum Genet 1996;59:810-817.
31. Chui D, Hennet T, Moremen KW, Freeze HH, Paulson JC, Schachter H, Fukuda MN, Marth JD. Cell-type-specific and physiologic roles of oligosaccharides. Glycobiology 1997;7:1019.
32. Miyoshi E, Nishikawa A, Iriara Y, Gu J, Sugiyama T, Hayashi N, Fusamoto H, Kamada T, Taniguchi N. N-acetylglucosaminyltransferase III and V messenger RNA levels in LEC rats during hepatocarcinogenesis. Cancer Res 1993;53:3899-3902.
33. Priatel JJ, Sarkar M, Schachter H, Marth JD. Isolation, characterization and inactivation of the mouse Mgat3 gene: the bisecting N-acetylglucosamine in asparagine-linked oligosaccharides appears dispensable for viability and reproduction. Glycobiology 1997;7:45-56.
34. Yoshimura M, Nishikawa A, Ihara Y, Taniguchi S, Taniguchi N. Suppression of lung metastasis of B16 mouse melanoma by N-acetylglucosaminyltransferase III gene transfection. Proc Natl Acad Sci USA 1995;92:8754-8758.
35. Yoshimura M, Ihara Y, Matsuzawa Y, Taniguchi N. Aberrant glycosylation of E-cadherin enhances cell-cell binding to suppress metastasis. J Biol Chem 1996;271:13811-13815.
36. Sheng Y, Yoshimura M, Inoue S, Oritani K, Nishiura T, Yoshida H, Ogawa M, Okajima Y, Matsuzawa Y, Taniguchi N. Remodeling of glycoconjugates on CD44 enhances cell adhesion to hyaluronate, tumor growth and metastasis in B16 melanoma cells expressing β1,4-N-acetylglucosaminyl-transferase III. Int J Cancer 1997;73:850-858.
37. Birchmeier W. E-cadherin as a tumor (invasion) suppressor gene. Bioessays 1995;17:97-99.
38. Schmits R, Filmus J, Gerwin N, Senaldi G, Kiefer F, Kundig T, Wakeham A, Shahinian A, Catzavelos C, Rak J, Furlonger C, Zakarian A, Simard JJ, Ohashi PS, Paige CJ, Gutierrez-Ramos JC, Mak TW. CD44 regulates hematopoietic progenitor distribution, granuloma formation, and tumorigenicity. Blood 1997;90:2217-2233.
39. Skelton TP, Zeng C, Nocks A, Stamenkovic I. Glycosylation provides both stimulatory and inhibitory effects on cell surface and soluble CD44 binding to hyaluronan. J Cell Biol 140:431-446.
40. Ihara Y, Sakamoto Y, Mihara M, Shimizu K, Taniguchi N. Overexpression of N-acetylglucosaminyltransferase III disrupts the tyrosine phosphorylation of Trk with resultant signaling dysfunction in PC12 cells treated with nerve growth factor. J Biol Chem 1997;272:9629-9634.
41. Rebbaa A, Yamamoto H, Saito T, Meuillet E, Kim P, Kersey DS, Bremer EG, Taniguchi N, Moskal JR. Gene transfection-mediated overexpression of beta1,4-N-acetylglucosamine bisecting oligosaccharides in glioma cell line U373 MG inhibits epidermal growth factor receptor function. J Biol Chem 1997;272:9275-9279.
42. Granovsky M, Fode C, Warren CE, Campbell RM, Marth JD, Pierce M, Fregien N, Dennis JW. GlcNAc-transferase V and core 2 GlcNAc-transferase expression in the developing mouse embryo. Glycobiology 1995;5:797-806.
43. Granovsky M, Cheng A, Waterhouse P, Dennis JW. Lymphocytes of N-acetylglucosaminyltransferase V null mice show hypersensitivity to T cell mitogens. Glycobiology 1997;7:1048.
44. Fernandes B, Sagman U, Auger M, Demetriou M, Dennis JW. β1-6 branched oligosaccharides as a marker of tumor progression in human breast and colon neoplasia. Cancer Res 51:716-723.
45. Yamashita K, Tachibana Y, Ohkura T, Kobata A. Enzymatic basis for the structural changes of asparagine-linked sugar chains of membrane glycoproteins of baby hamster kidney cells induced by polyoma transformation. J Biol Chem 260:3963-3969.
46. Buckhaults P, Chen L, Fregien N, Pierce M. Transcriptional regulation of N-acetylglucosaminyltransferase V by the src oncogene. J Biol Chem 1997;272:19575-19581.
47. Galang CK, Garcia-Ramirez J, Solski PA, Westwick JK, Der CJ, Neznanov NN, Oshima RG, Hauser CA. Oncogenic Neu/ErbB-2 increases ets, AP-1, and NF-kappaB-dependent gene expression, and inhibiting ets activation blocks Neu-mediated cellular transformation. J Biol Chem 1996;271:7992-7998.
48. Lu Y, Pelling JC, Chaney WG. Tumor cell surface β1-6 branched oligosaccharides and lung metastasis. Clin Exp Metastasis 1994;12:47-54.
49. Seberger R, Chaney WG. Control of metastasis by Asn-linked β1-6 branched oligosaccharides in mouse mammary cancer cells. Glycobiology 1999;9:235-241.
50. Demetriou M, Nabi IR, Coppolino M, Dedhar S, Dennis JW. Reduced contact-inhibition and substratum adhesion in epithelial cells expressing GlcNAc-transferase V. J.Cell Biol 1995;130:383-392.
51. Bell JE, Beyer TA, Hill RL. The kinetic mechansim of bovine milk galactosyltransferase. The role of alpha-lactalbumin. J Biol Chem 1976; 251:3003-3013.
52. Asano M, Furukawa K, Kido M. Matsumoto S, Umesaki Y, Kochibe N, Iwakura Y. Growth retardation and early death of β1,4-galactosyltransferase knockout mice with augmented proliferation and abnormal differentiation of epithelial cells. EMBO J 16:1850-1857.
53. Lo N-W, Shaper JH, Pevsner J, Shaper NL. The expanding β4-galactosyltransferase gene family: messages from the databanks. Glycobiology 8:517-526.
54. Phillips ML, Schwartz BR, Etzioni A, Bayer R, Ochs HD, Paulson JC, Harlan JM. Neutrophil adhesion in leukocyte adhesion deficiency syndrome type 2. J Clin Invest 1995;96:2898-2906.
55. Prieto PA, Larsen RD, Cho M, Rivera HN, Shilatifard A, Lowe JB, Cummings RD, Smith DF. Expression of human H-type alpha1,2-fucosyltransferase encoding for blood group H(O) antigen in Chinese hamster ovary cells. Evidence for preferential fucosylation and truncation of polylactosamine sequences. J Biol Chem 1997;272:2089-2097.
56. Orntoft TF, Vestergaard EM, Holmes E, Jakobsen JS, Grunnet N, Mortensen M, Johnson P, Bross P Gregersen N, Skorstengaard K, Jensen UB, Bolund L, Wolf H. Influence of Lewis α1-3/4-L-fucosyltransferase (FUT3) gene mutations on enzyme activity, erythrocyte phenotyping, and circulating tumor marker sialyl-Lewis a levels. J Biol Chem 1996;271:32260-32268.
57. Mollicone R, Reguigne I, Fletcher A, Aziz A, Rustam M, Weston BW, Kelly RJ, Lowe JB, Oriol R. Molecular basis for plasma alpha(1,3)-fucosyltransferase gene deficiency (FUT6). J Biol Chem 1994;269:12662-12671.
58. Kelly RJ, Ernst LK, Larsen RD, Bryant JG, Robinson JS, Lowe JB. Molecular basis for H blood group deficiency in Bombay (Oh) and para-Bombay individuals. Proc Natl Acad Sci USA 1994;91:5843-5847.
59. Knibbs RN, Craig RA, Natsuka S, Chang A, Cameron M, Lowe JB, Stoolman LM. The fucosyltransferase FucT-VII regulates E-selectin ligand synthesis in human T cells. J Cell Biol 1996;133:911-920.
60. Springer TA. Traffic signals for lymphocyte recirculation and leukocyte migration: the multistep paradigm. Cell 1994;76:301-314.
61. Maly P, Thall AD, Petryniak B, Rogers CE, Smith PL, Marks RM, Kelly RJ, Gersten KM, Cheng G, Saunders TL, Camper SA, Camphausen RT, Sullivan FX, Isogai Y, Hindsgaul O, von Andrian UH, Lowe JB. The α(1,3)fucosyltransferase VII controls leukocyte trafficking through an essential role in L-, E-, and P-selectin ligand biosynthesis. Cell 1996;86: 643-653.
62. Frenette PS, Mayadas TN, Rayburn H, Hynes RO, Wagner DD. Susceptibility to infection and altered hematopoiesis in mice deficient in both P-and E-selectins. Cell 1996;84:563-574.
63. Boren T, Normark S, Falk P. Helicobacter pylori: molecular basis for host recognition and bacterial adherence. Trends Microbiol 1994;2:221-228.
64. Tsuji, S. Molecular cloning and functional analysis of sialyltransferases. J Biochem (Tokyo) 1996;120:1-13.
65. Pritchett TJ, Brossmer R, Rose U, Paulson JC. Recognition of monovalent sialosides by influenza virus H3 hemagglutinin. Virology 1987;160:502-506.
66. Hennet T, Chui D, Paulson JC, Marth JD. Immune regulation by the ST6Gal sialyltranslerase. Proc Natl Acad Sci USA 1998;95:4504-4509
67. Ness PM. The association of Tn and leukemia. Haematologia (Budap) 1983;16:93-98.
68. Thurnher M, Rusconi S, Berger EG. Persistent repression of a functional allele can be responsible for galactosyltransferase deficiency in Tn syndrome. J Clin Invest 1993;91, 2103-2110.
69. Li F, Wilkins PP, Crawley S, Weinstein J, Cummings RD, McEver RP. Post-translational modifications of recombinant P-selectin glycoprotein ligand-1 required for binding to P- and E-selectin. J Biol Chem 1996;271: 3255-3264.
70. Perillo NL, Pace KE, Seilhamer JJ, Baum LG. Apoptosis of T cells mediated by galectin-1. Nature 1995;378, 736-739.
71. Piller F, Piller V, Fox RI, Fukuda M. Human T-lymphocyte activation is associated with changes in O-glycan biosynthesis. J Biol Chem 1988;263, 5146-15150.
72. Cyster JG, Shotton DM, Williams AF. The dimensions of the T lymphocyte glycoprotein leukosialin and identification of linear protein epitopes that can be modified by glycosylation. EMBO J 1991;10, 893-902.
73. Yonemura S, Hirao M, Doi Y, Takahashi N, Kondo T, Tsukita S. Ezrin/radixin/ moesin (ERM) proteins bind to a positively charged amino acid cluster in the juxta-membrane cytoplasmic domain of CD44, CD43, and ICAM-2. J Cell Biol 1998;140:885-895.
74. McEvoy LM, Sun H, Frelinger JG, Butcher EC. Anti-CD43 inhibition of T cell homing. J Exp Med 1997;185:1493-1498.
75. Manjunath N, Correa M, Ardman M, Ardman B. Negative regulation of T-cell adhesion and activation by CD43. Nature 1995;377:535-538.
76. Tsuboi S, Fukuda M. Branched O-linked oligosaccharides ectopically expressed in transgenic mice reduce primary T-cell immune responses. EMBO J 1997;16:6364-6373.
77. Shimodaira K, Nakayama J. Nakamura N, Hasebe O, Katsuyama T, Fukuda M. Carcinoma-associated expression of core 2 β-1,6-N-Acetylglucosaminyltransferase gene in human colorectal cancer: Role of O-glycans in tumor progression. Cancer Res 1997;57:5201-5206.
78. Nishio Y, Warren CE, Buczek-Thomas JA, Rulfs J, Koya D, Aiello LP, Feener EP, Miller TB Jr, Dennis JW, King GL. Identification and characterization of a gene regulating enzymatic glycosylation which is induced by diabetes and hyperglycemia specifically in rat cardiac tissue. J Clin Invest 1995;96:1759-1767.
79. Perillo NL, Marcus ME, Baum LG. Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death. J Mol Med 1998;76:402-412
80. Hagen FK, Nehrke K. cDNA cloning and expression of a family of UDP-N-acetyl-D-galactosamine: Polypeptide N-Acetylgalactosaminyl transferase sequence homologs from Caenorhabditis elegans. J Biol Chem 1998;273:8268-8277.